T-independent responses to polysaccharides in humans mobilize marginal zone B cells prediversified against gut bacterial antigens

Marginal zone (MZ) B cells are one of the main actors of T-independent (TI) responses in mice. To identify the B cell subset(s) involved in such responses in humans, we vaccinated healthy individuals with Pneumovax, a model TI vaccine. By high-throughput repertoire sequencing of plasma cells (PCs) isolated 7 days after vaccination and of different B cell subpopulations before and after vaccination, we show that the PC response mobilizes large clones systematically, including an immunoglobulin M component, whose diversification and amplification predated the pneumococcal vaccination. These clones could be mainly traced back to MZ B cells, together with clonally related IgA+ and, to a lesser extent, IgG+CD27+ B cells. Recombinant monoclonal antibodies isolated from large PC clones recognized a wide array of bacterial species from the gut flora, indicating that TI responses in humans largely mobilize MZ and switched B cells that most likely prediversified during mucosal immune responses against bacterial antigens and acquired pneumococcal cross-reactivity through somatic hypermutation.

Errataetall:

CommentIn: Immunol Lett. 2023 Apr-May;256-257:66-67. - PMID 37040847

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

Science immunology - 8(2023), 79 vom: 27. Jan., Seite eade1413

Sprache:

Englisch

Beteiligte Personen:

Weller, Sandra [VerfasserIn]
Sterlin, Delphine [VerfasserIn]
Fadeev, Tatiana [VerfasserIn]
Coignard, Eva [VerfasserIn]
Verge de Los Aires, Alba [VerfasserIn]
Goetz, Clara [VerfasserIn]
Fritzen, Rémi [VerfasserIn]
Bahuaud, Mathilde [VerfasserIn]
Batteux, Frederic [VerfasserIn]
Gorochov, Guy [VerfasserIn]
Weill, Jean-Claude [VerfasserIn]
Reynaud, Claude-Agnès [VerfasserIn]

Links:

Volltext

Themen:

Antigens, Bacterial
Journal Article
Pneumococcal Vaccines
Polysaccharides
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 03.02.2023

Date Revised 03.10.2023

published: Print-Electronic

CommentIn: Immunol Lett. 2023 Apr-May;256-257:66-67. - PMID 37040847

Citation Status MEDLINE

doi:

10.1126/sciimmunol.ade1413

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM352166363